Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Repligen receives Phase II SBIR grant for angiogenesis research

April 21, 1998

New water-soluble dolastatin derivatives with potent antitumor activity

April 21, 1998

Phase I data reported for antitumor bisnaphthalimide DMP-840

April 21, 1998

Tricyclic compounds inhibiting protein farnesyltransferase claimed by Schering-Plough

April 21, 1998

mRNA splicing appears to trigger metastasis in prostate cancer

April 21, 1998

RPR's Gliadel Wafer approved in Argentina

April 20, 1998

P&U claims new distamycin derivatives and their use as antitumor and antiviral agents

April 20, 1998

Synthetic dolastatin derivatives as antitumor agents

April 20, 1998

Idun seeks licensing partners for apoptosis regulators

April 20, 1998

SuperGen's Nipent granted orphan drug status

April 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...